Healthcare -
Biotechnology - NASDAQ - US
$ 493.756
-0.384 %
$ 52.4 B
Market Cap
12.27
P/E
REGN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities REGN - Regeneron Pharmaceuticals, Inc.
-2.47 B
LAST VALUE
19.24%
2 YEAR CAGR
-4.01%
5 YEAR CAGR
-19.35%
10 YEAR CAGR